Eli Lilly, AstraZeneca scrap trials of experimental Alzheimer’s drug
June 12, 2018 at 19:41 PM EDT
AstraZeneca PLC and Eli Lilly & Co. on Tuesday scrapped two late-stage trials of an experimental Alzheimer’s drug they were co-developing, the latest blow in the long quest to find a breakthrough for the memory-robbing disorder.